Key facts
- This page summarizes Joseph H. Capper's Form 4 filing for TELA Bio, Inc. (TELA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Sep 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.19 to $1.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.